{
    "Trade/Device Name(s)": [
        "Granada Medium"
    ],
    "Submitter Information": "Hardy Diagnostics",
    "510(k) Number": "K173903",
    "Predicate Device Reference 510(k) Number(s)": [
        "K163042"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "PQZ"
    ],
    "Summary Letter Date": "December 21, 2017",
    "Summary Letter Received Date": "December 26, 2017",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.2360"
    ],
    "Regulation Name(s)": [
        "Selective culture medium"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Group B Streptococcus (GBS)"
    ],
    "Specimen Type(s)": [
        "Vaginal swab",
        "Rectal swab"
    ],
    "Specimen Container(s)": [
        "ESwab\u2122 Liquid Amies",
        "Sponge based Liquid Amies",
        "Sponge based Stuart\u2019s liquid",
        "TransPRO\u2122 Liquid Amies",
        "Healthlink Liquid Amies",
        "Amies Gel",
        "Liquid Stuart\u2019s",
        "Stuart\u2019s Gel",
        "Amies Charcoal"
    ],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Selective and differential agar culture",
        "Chromogenic reaction"
    ],
    "Methodologies": [
        "Manual visual interpretation"
    ],
    "Submission Type(s)": [
        "Reagent",
        "Agar",
        "Culture medium"
    ],
    "Document Summary": "FDA 510(k) summary for Hardy Diagnostics Granada Medium, a selective and differential agar for qualitative detection of Group B Streptococcus (GBS) from enriched vaginal/rectal swab cultures",
    "Indications for Use Summary": "Qualitative detection of Group B Streptococcus (GBS) from LIM Broth enrichment cultures of vaginal/rectal swabs from antepartum women following 18-24 hours of incubation; orange colonies indicate \u03b2-hemolytic GBS, white colonies require further testing, not intended for infection diagnosis or treatment guidance",
    "fda_folder": "Microbiology"
}